Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_assertion type Assertion NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_head.
- NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_assertion description "[In conclusion, GD2-CAR T cells can induce complete tumor responses in patients with active neuroblastoma; these CAR T cells may have extended, low-level persistence in patients, and such persistence was associated with longer survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_provenance.
- NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_assertion evidence source_evidence_literature NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_provenance.
- NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_assertion SIO_000772 21984804 NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_provenance.
- NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_assertion wasDerivedFrom befree-20150227 NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_provenance.
- NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_assertion wasGeneratedBy ECO_0000203 NP282850.RAVS1xNGVvT7ge-Y05jplR8kWxwxIaPSHIUwZJlleCcRg130_provenance.